Ozics

Ozics’ vision is to develop a range of materials and implants that deliver the clinical benefits outlined above.

Ozics was founded by experts in orthopaedic surgery and biomaterial science to commercialise a family of surgical implants to first address the screw purchase problems currently experienced with osteosynthesis and shortcomings in the treatment of vertebral compression fractures (VCF ). Following a successful execution of a series of clinical trials, Ozics is determined to bring to the market a minimally invasive fracture fixation system to be used in load bearing fractures, such as hip, as a stand-alone device allowing immediate unassisted mobility. Ozics’ vision is to develop a range of materials and implants that deliver the clinical benefits outlined above. The basic material is a composite of a dimethylacrylate based polymer matrix and ceramic filler, containing silicate glass and hydroxyapatite (HA). The material can be administered by injection to provide a custom-made, intra-bony implant. Used primarily as a stand-alone device, it can also be used in conjunction with other fixation approaches and devices. Ozics’ first product offering, CompO6 reinforced bone composite, is an injectable bone cement indicated for vertebral compression fractures and to aid screw purchase in trauma procedures throughout the entire skeleton.